We used deep CD8+ cell single-cell RNA sequencing (scRNA-seq) data from lung tumor, adjacent normal tissues, and peripheral blood from 14 treatment-naïve NSCLC patients. This evidence concerns the gene CD8A and non-small cell lung carcinoma.